Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 171
9
Diseases
9
Unique genes
0.280
Avg. similarity score
Paroxysmal extreme pain disorder
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Paroxysmal extreme pain disorder
Congenital insensitivity to pain
Erythromelalgia
Congenital pain insensitivity
Chronic pain
Primary erythromelalgia
hereditary sensory and autonomic neuropathy type 7
Episodic pain syndrome
Metaphyseal enchondromatosis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Paroxysmal extreme pain disorder | 8 | 8 | 4 |
| Congenital insensitivity to pain | 7 | 7 | 6 |
| Erythromelalgia | 7 | 7 | 3 |
| Congenital pain insensitivity | 6 | 6 | 4 |
| Chronic pain | 5 | 5 | 1 |
| Primary erythromelalgia | 5 | 5 | 1 |
| hereditary sensory and autonomic neuropathy type 7 | 5 | 5 | 1 |
| Episodic pain syndrome | 4 | 4 | 3 |
| Metaphyseal enchondromatosis | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SCN11A | 6 / 9 | Congenital insensitivity to pain, Congenital pain insensitivity, Episodic pain syndrome, Erythromelalgia and 2 more |
| SCN9A | 6 / 9 | Chronic pain, Congenital insensitivity to pain, Congenital pain insensitivity, Erythromelalgia and 2 more |
| SCN10A | 4 / 9 | Congenital insensitivity to pain, Episodic pain syndrome, Erythromelalgia, Paroxysmal extreme pain disorder |
| IDH1 | 2 / 9 | Metaphyseal enchondromatosis, Paroxysmal extreme pain disorder |
| PRDM12 | 2 / 9 | Congenital insensitivity to pain, Congenital pain insensitivity |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Phase 0 - rapid depolarisation | Reactome | 3 / 44 | 91.0× | 3.80e-6 | 1.52e-4 ✓ sig. |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | Reactome | 1 / 1 | 1,334× | 7.49e-4 | 1.09e-2 ✓ sig. |
| NADPH regeneration | Reactome | 1 / 1 | 1,334× | 7.49e-4 | 1.09e-2 ✓ sig. |
| TRKA activation by NGF | Reactome | 1 / 2 | 667× | 1.50e-3 | 1.85e-2 ✓ sig. |
| NFG and proNGF binds to p75NTR | Reactome | 1 / 2 | 667× | 1.50e-3 | 1.85e-2 ✓ sig. |
| Inflammatory mediator regulation of TRP channels | KEGG | 2 / 99 | 27.0× | 2.33e-3 | 2.55e-2 ✓ sig. |
| Axonal growth stimulation | Reactome | 1 / 4 | 334× | 2.99e-3 | 3.07e-2 ✓ sig. |
| NGF processing | Reactome | 1 / 4 | 334× | 2.99e-3 | 3.07e-2 ✓ sig. |
| ARMS-mediated activation | Reactome | 1 / 5 | 267× | 3.74e-3 | 3.59e-2 ✓ sig. |
| NADE modulates death signalling | Reactome | 1 / 6 | 222× | 4.49e-3 | 4.08e-2 ✓ sig. |
| PI3K/AKT activation | Reactome | 1 / 9 | 148× | 6.73e-3 | 5.32e-2 |
| Retrograde neurotrophin signalling | Reactome | 1 / 11 | 121× | 8.22e-3 | 6.07e-2 |
| Formation of annular gap junctions | Reactome | 1 / 11 | 121× | 8.22e-3 | 6.07e-2 |
| Frs2-mediated activation | Reactome | 1 / 12 | 111× | 8.96e-3 | 6.42e-2 |
| Gap junction degradation | Reactome | 1 / 12 | 111× | 8.96e-3 | 6.42e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sensory perception of pain | GO:0019233 | 5 / 44 | 236× | 7.16e-12 | 2.71e-9 ✓ sig. |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 3 / 8 | 779× | 4.32e-9 | 8.18e-7 ✓ sig. |
| detection of temperature stimulus involved in sensory perception of pain | GO:0050965 | 3 / 20 | 311× | 8.77e-8 | 1.08e-5 ✓ sig. |
| cardiac muscle cell action potential involved in contraction | GO:0086002 | 3 / 24 | 260× | 1.56e-7 | 1.75e-5 ✓ sig. |
| circadian rhythm | GO:0007623 | 3 / 82 | 76.0× | 6.71e-6 | 3.79e-4 ✓ sig. |
| membrane depolarization during action potential | GO:0086010 | 2 / 10 | 415× | 9.26e-6 | 4.92e-4 ✓ sig. |
| detection of mechanical stimulus involved in sensory perception of pain | GO:0050966 | 2 / 14 | 297× | 1.87e-5 | 8.50e-4 ✓ sig. |
| cellular response to cold | GO:0070417 | 2 / 15 | 277× | 2.16e-5 | 9.54e-4 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 4 / 404 | 20.6× | 2.49e-5 | 1.06e-3 ✓ sig. |
| sodium ion transmembrane transport | GO:0035725 | 3 / 134 | 46.5× | 2.93e-5 | 1.20e-3 ✓ sig. |
| behavioral response to pain | GO:0048266 | 2 / 18 | 231× | 3.14e-5 | 1.27e-3 ✓ sig. |
| response to pain | GO:0048265 | 2 / 19 | 219× | 3.51e-5 | 1.38e-3 ✓ sig. |
| sodium ion transport | GO:0006814 | 3 / 144 | 43.3× | 3.64e-5 | 1.42e-3 ✓ sig. |
| transmembrane transport | GO:0055085 | 4 / 557 | 14.9× | 8.73e-5 | 2.74e-3 ✓ sig. |
| response to cold | GO:0009409 | 2 / 31 | 134× | 9.52e-5 | 2.91e-3 ✓ sig. |